Structural determinants of MALT1 protease activity

Journal of Molecular Biology

Volumn 419, Issue 1-2, 2012, Pages 4-21

  Wiesmann, Christian ^a   Leder, Lukas ^a   Blank, Jutta ^a   Bernardi, Anna ^a   Melkko, Samu ^a   Decock, Arnaud ^a   D'Arcy, Allan ^a   Villard, Frederic ^a   Erbel, Paulus ^a   Hughes, Nicola ^a   Freuler, Felix ^a   Nikolay, Rainer ^a   Alves, Juliano ^b   Bornancin, Frederic ^a   Renatus, Martin ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

Author keywords

caspase; CBM (CARD11 BCL10 MALT1); dimerization; protease; structure

Indexed keywords

CASPASE 2; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; IMMUNOGLOBULIN; MEMBRANE PROTEIN; PROTEIN BCL 10; PROTEN MALT1; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HEK293; CONFORMATIONAL TRANSITION; DIMERIZATION; ENZYME ACTIVATION; ENZYME ACTIVITY; OOCYTE CLEAVAGE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION;

EID: 84860307519     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2012.02.018     Document Type: Article

References (47)

1. Che T.J., You Y., Wang D.H., Tanner M.J., Dixit V.M., and Lin X. MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-κB activation J. Biol. Chem. 279 2004 15870 15876
2. Akagi T., Motegi M., Tamura A., Suzuki R., Hosokawa Y., and Suzuki H. A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue Oncogene 18 1999 5785 5794
3. Dierlamm J., Baens M., Wlodarska I., Stefanova-Ouzounova M., Hernandez J.M., and Hossfeld D.K. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas Blood 93 1999 3601 3609
4. Snipas S.J., Wildfang E., Nazif T., Christensen L., Boatright K.M., and Bogyo M. Characteristics of the caspase-like catalytic domain of human paracaspase Biol. Chem. 385 2004 1093 1098
5. Uren A.G., O'Rourke K., Aravind L., Pisabarro M.T., Seshagiri S., Koonin E.V., and Dixit V.M. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma Mol. Cell 6 2000 961 967
6. Coornaert B., Baens M., Heyninck K., Bekaert T., Haegman M., and Staal J. T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-κB inhibitor A20 Nat. Immunol. 9 2008 263 271
7. Rebeaud F., Hailfinger S., Posevitz-Fejfar A., Tapernoux M., Moser R., and Rueda D. The proteolytic activity of the paracaspase MALT1 is key in T cell activation Nat. Immunol. 9 2008 272 281
8. Vakifahmetoglu-Norberg H., and Zhivotovsky B. The unpredictable caspase-2: what can it do? Trends Cell Biol. 20 2010 150 159
9. Mace P.D., and Riedl S.J. Molecular cell death platforms and assemblies Curr. Opin. Cell Biol. 22 2010 828 836
10. Yu J.W., Jeffrey P.D., Ha J.Y., Yang X.L., and Shi Y.G. Crystal structure of the mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1) paracaspase region Proc. Natl Acad. Sci. USA 108 2011 21004 21009
11. Qiu L., and Dhe-Paganon S. Oligomeric structure of the MALT1 tandem Ig-like domains PLoS One 6 2011 e23220
12. Zhou H.L., Du M.Q., and Dixit V.M. Constitutive NF-κB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity Cancer Cell 7 2005 425 431
13. Lenz G., Davis R.E., Ngo V.N., Lam L., George T.C., and Wright G.W. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma Science 319 2008 1676 1679
14. Thome M. Multifunctional roles for MALT1 in T-cell activation Nat. Rev., Immunol. 8 2008 495 500
15. Boatright K.M., and Salvesen G.S. Mechanisms of caspase activation Curr. Opin. Cell Biol 15 2003 725 731
16. Chang D.W., Ditsworth D., Liu H.T., Srinivasula S.M., Alnemri E.S., and Yang X.L. Oligomerization is a general mechanism for the activation of apoptosis initiator and inflammatory procaspases J. Biol. Chem. 278 2003 16466 16469
17. Baliga B.C., Read S.H., and Kumar S. The biochemical mechanism of caspase-2 activation Cell Death Differ. 11 2004 1234 1241
18. Boatright K.M., Renatus M., Scott F.L., Sperandio S., Shin H., and Pedersen I.M. A unified model for apical caspase activation Mol. Cell 11 2003 529 541
19. Chai J.J., Wu Q., Shiozaki E., Srinivasula S.M., Alnemri E.S., and Shi Y.G. Crystal structure of a procaspase-7 zymogen: mechanisms of activation and substrate binding Cell 107 2001 399 407
20. Pop C., Timmer J., Sperandio S., and Salvesen G.S. The apoptosome activates caspase-9 by dimerization Mol. Cell 22 2006 269 275
21. Yin Q., Park H.H., Chung J.Y., Lin S.C., Lo Y.C., and Da Graca L.S. Caspase-9 holoenzyme is a specific and optimal procaspase-3 processing machine Mol. Cell 22 2006 259 268
22. Oberst A., Pop C., Tremblay A.G., Blais V., Denault J.B., Salvesen G.S., and Green D.R. Inducible dimerization and inducible cleavage reveal a requirement for both processes in caspase-8 activation J. Biol. Chem. 285 2010 16632 16642
23. Shiozaki E.N., Chai J.J., Rigotti D.J., Riedl S.J., Li P.W., and Srinivasula S.M. Mechanism of XIAP-mediated inhibition of caspase-9 Mol. Cell 11 2003 519 527
24. 2 homodimer Cell 78 1994 343 352
25. Wilson K.P., Black J.A.F., Thomson J.A., Kim E.E., Griffith J.P., and Navia M.A. Structure and mechanism of interleukin-1β converting-enzyme Nature 370 1994 270 275
26. Brett T.J., Traub L.M., and Fremont D.H. Accessory protein recruitment motifs in clathrin-mediated endocytosis Structure 10 2002 797 809
27. Owen D.J., Vallis Y., Noble M.E.M., Hunter J.B., Dafforn T.R., Evans P.R., and McMahon H.T. A structural explanation for the binding of multiple ligands by the α-adaptin appendage domain Cell 97 1999 805 815
28. Traub L.M., Downs M.A., Westrich J.L., and Fremont D.H. Crystal structure of the α appendage of AP-2 reveals a recruitment platform for clathrin-coat assembly Proc. Natl Acad. Sci. USA 96 1999 8907 8912
29. Sun L.J., Deng L., Ea C.K., Xia Z.P., and Chen Z.J.J. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes Mol. Cell 14 2004 289 301
30. Noels H., van Loo G., Hagens S., Broeckx V., Beyaert R., Marynen P., and Baens M. A novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-κB activation by API2 center dot MALT1 fusions J. Biol. Chem. 282 2007 10180 10189
31. Renatus M., Stennicke H.R., Scott F.L., Liddington R.C., and Salvesen G.S. Dimer formation drives the activation of the cell death protease caspase 9 Proc. Natl Acad. Sci. USA 98 2001 14250 14255
32. Schweizer A., Briand C., and Grutter M.G. Crystal structure of caspase-2, apical initiator of the intrinsic apoptotic pathway J. Biol. Chem. 278 2003 42441 42447
33. Harris J.L., Backes B.J., Leonetti F., Mahrus S., Ellman J.A., and Craik C.S. Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries Proc. Natl Acad. Sci. USA 97 2000 7754 7759
34. Vercammen D., van de Cotte B., De Jaeger G., Eeckhout D., Casteels P., and Vandepoele K. Type II metacaspases Atmc4 and Atmc9 of Arabidopsis thaliana cleave substrates after arginine and lysine J. Biol. Chem. 279 2004 45329 45336
35. Hailfinger S., Nogai H., Pelzer C., Jaworski M., Cabalzar K., and Charton J.E. Malt1-dependent RelB cleavage promotes canonical NF-κB activation in lymphocytes and lymphoma cell lines Proc. Natl Acad. Sci. USA 108 2011 14596 14601
36. Rosebeck S., Madden L., Jin X.H., Gu S.F., Apel I.J., and Appert A. Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-κB activation Science 331 2011 468 472
37. Staal J., Driege Y., Bekaert T., Demeyer A., Muyllaert D., and Van Damme P. T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1 EMBO J. 30 2011 1742 1752
38. Stennicke H.R., Renatus M., Meldal M., and Salvesen G.S. Internally quenched fluorescent peptide substrates disclose the subsite preferences of human caspases 1, 3, 6, 7 and 8 Biochem. J. 350 2000 563 568
39. Malinverni C., Unterreiner A., Staal J., Demeyer A., Galaup M., and Luyten M. Cleavage by MALT1 induces cytosolic release of A20 Biochem. Biophys. Res. Commun. 400 2010 543 547
40. Talanian R.V., Quinlan C., Trautz S., Hackett M.C., Mankovich J.A., and Banach D. Substrate specificities of caspase family proteases J. Biol. Chem. 272 1997 9677 9682
41. Thornberry N.A., Ranon T.A., Pieterson E.P., Rasper D.M., Timkey T., and Garcia-Calvo M. A combinatorial approach defines specificities of members of the caspase family and granzyme B: functional, relationships established for key mediators of apoptosis J. Biol. Chem. 272 1997 17907 17911
42. Nilsson B., Moks T., Jansson B., Abrahmsen L., Elmblad A., and Holmgren E. A synthetic IgG-binding domain based on staphylococcal protein A Protein Eng. 1 1987 107 113
43. Kabsch W. Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants J. Appl. Crystallogr. 26 1993 795 800
44. Kroemer M., Dreyer M.K., and Wendt K.U. APRV-a program for automated data processing, refinement and visualization Acta Crystallogr., Sect. D: Biol. Crystallogr. 60 2004 1679 1682
45. Storoni L.C., Mccoy A.J., and Read R.J. Likelihood-enhanced fast rotation functions Acta Crystallogr., Sect. D: Biol. Crystallogr. 60 2004 432 438
46. Emsley P., and Cowtan K. Coot: model-building tools for molecular graphics Acta Crystallogr., Sect. D: Biol. Crystallogr. 60 2004 2126 2132
47. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method Acta Crystallogr., Sect. D: Biol. Crystallogr. 53 1997 240 255